Genome-wide Analysis of Long Noncoding RNA Expression Profiles in Patients with Non-Alcoholic Fatty Liver Disease

被引:61
|
作者
Sun, Chuanzheng [1 ]
Liu, Xunyang [1 ]
Yi, Zhongjie [1 ]
Xiao, Xuefei [1 ]
Yang, Mingshi [1 ]
Hu, Gui [1 ]
Liu, Huaizheng [1 ]
Liao, Liangkan [1 ]
Huang, Feizhou [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 3, Emergency Dept, Changsha 410013, Hunan, Peoples R China
关键词
long non-coding RNA; nonalcoholic fatty liver disease (NAFLD); expression profile; mRNA; INSIGHTS; STEATOHEPATITIS; CARCINOMA;
D O I
10.1002/iub.1442
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder poising burgeoning health problem to humans. Recent studies have shown that long non-coding RNA (lncRNA) plays critical roles in a myriad of biological processes and human diseases. Since the roles of lncRNA in NAFLD remain unknown, they were investigated in the study. Microarray expression profiling of mRNAs and lncRNAs was conducted using RNA extracted from patients with and without NAFLD. One thousand seven hundred thirty-five lncRNAs and 1485 mRNA were found differentially expressed in NAFLD samples compared with those in control samples. Among them 535 and 1,200 lncRNAs were upregulated and downregulated in NAFLD, respectively; 760 and 725 mRNAs were upregulated and downregulated in NAFLD, respectively. Moreover, seven lncRNAs and seven mRNAs that were highly up-or downregulated in NAFLD samples were validated by quantitative real-time polymer chain reactions. Kyoto Encyclopedia of Genes and Genomes pathway analysis and Gene Ontology analysis for the differentially expressed mRNAs showed that these RNAs are involved in various metabolic processes, cellular components, and molecular functions. Our findings indicate that the expression profiles of lncRNAs have changed in NAFLD as compared with normal liver, and the identified regulated RNAs may provide novel insight into the molecular mechanisms underlying the disease and potential novel diagnostic or therapeutic targets for NAFLD. (C) 2015 IUBMB Life.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 50 条
  • [41] Long noncoding RNA study: Genome-wide approaches
    Tao, Shuang
    Hou, Yarui
    Diao, Liting
    Hu, Yanxia
    Xu, Wanyi
    Xie, Shujuan
    Xiao, Zhendong
    [J]. GENES & DISEASES, 2023, 10 (06) : 2491 - 2510
  • [42] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    [J]. LANCET, 2021, 397 (10290): : 2212 - 2224
  • [43] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    [J]. BMC MEDICINE, 2017, 15
  • [44] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [45] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [46] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    [J]. CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [47] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    [J]. JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [48] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [49] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    [J]. HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [50] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    [J]. LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270